Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;20(11):3362-3363.
doi: 10.1111/jocd.14512. Epub 2021 Oct 11.

Effect of COVID-19 pandemic on psoriatic patients dermatology admissions and biologic treatment adherences: A single-center retrospective study

Ahmet Kağan Özdemir  1 , Yıldız Hayran  1 , Orhan Şen  1 , Akın Aktaş  1
Affiliations

Effect of COVID-19 pandemic on psoriatic patients dermatology admissions and biologic treatment adherences: A single-center retrospective study

Ahmet Kağan Özdemir et al. J Cosmet Dermatol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Ahmet Kağan Özdemir, Dr. Yıldız Hayran, Dr. Orhan Şen, and Dr. Akın Aktaş do not report any conflict of interest.

Figures

FIGURE 1
FIGURE 1
With the start of the pandemic, all psoriatic patients' follow‐up admission rates were reduced, but frequency reduction was more significant in patients under biological therapies
FIGURE 2
FIGURE 2
Percentage of new initiators of biological therapies to all biologic users increased during the early and late COVID period
See this image and copyright information in PMC

References

    1. Kartal SP, Çelik G, Sendur N, et al. Multicenter study evaluating the impact of COVID‐19 outbreak on dermatology outpatients in Turkey. Dermatol Ther. 2020;33(6):e14485. 10.1111/dth.14485 - DOI - PubMed
    1. Torres T, Pereira M, Paiva Lopes MJ, et al. Dermatologists' attitude towards psoriasis treatment during the COVID‐19 pandemic. DIC. 2021;10:1‐9. 10.7573/dic.2021-4-4 - DOI - PMC - PubMed
    1. EL‐Komy MHM, Abdelnaby A, El‐Kalioby M. How does COVID‐19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross‐sectional survey study. J Cosmet Dermatol. 2021;20(6):1573‐1579. 10.1111/jocd.14104 - DOI - PMC - PubMed
    1. Polat Ekinci A, Pehlivan G, Gökalp MO. Surveillance of psoriatic patients on biologic treatment during the COVID‐19 pandemic: a single‐center experience. Dermatol Ther. 2021;34(1):e14700. 10.1111/dth.14700 - DOI - PubMed
    1. Penso L, Dray‐Spira R, Weill A, Zureik M, Sbidian E. Drop in biological initiation for patients with psoriasis during the COVID‐19 pandemic. Br J Dermatol. 2021;185:bjd.20406. 10.1111/bjd.20406 - DOI - PMC - PubMed

Substances